ABBV Competitors
AbbVie Inc.
$283.48
+$9.12(+3.32%)
70
Overall
60
Value
100
Tech
50
Quality
Market Cap
$484.83B
Volume
5.59M
52W Range
$190.75 - $277.60
Target Price
$281.70
ABBV competitors: PFE, BMY, LLY, AMGN, GILD. AbbVie Inc. is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
ABBV Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| PFE Pfizer Inc. | $29.23 | $161.70B | $2.96 | 5.89% | 70 |
| BMY Bristol-Myers Squibb Company | $59.21 | $115.76B | $6.80 | 3.19% | 63 |
| LLY Eli Lilly and Company | $1211.57 | $1.10T | $36.19 | 0.55% | 60 |
| AMGN Amgen Inc. | $425.63 | $223.19B | $22.94 | 2.34% | 65 |
| GILD Gilead Sciences, Inc. | $153.54 | $183.41B | $-0.47 | 2.12% | 73 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ABBV | $283.48 | +3.3% | 5.59M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |